⌘K
Loading ticker…
Adaptive Biotechnologies Corporation Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Adaptive Biotechnologies Corporation Common Stock (ADPT) has a 3-month relative strength percentile of 89 and a leadership percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 66. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.6%, relative volume 1.78×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 89, Market Stance is mixed at 47, A/D rating C
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
ADPT is held by 7 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $64M notional. Top 3 carry $138M.
Top 7 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $64M |
| IWMiShares Russell 2000 ETF | 0.07% | $51M |
| VBVanguard Small Cap ETF | 0.01% | $23M |
| VXFVanguard Extended Market ETF | 0.02% | $18M |
| IWOiShares Russell 2000 Growth ETF | 0.14% | $17M |
| VBKVanguard Small-Cap Growth ETF | 0.03% | $13M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ADPT Jan avg: 9.86% median: 17.63% win: 75% σ: 24.13% n: 4 2022-04-12 → 2026-05-29 | ADPT Feb avg: -0.65% median: -0.59% win: 50% σ: 11.91% n: 4 2022-04-12 → 2026-05-29 | ADPT Mar avg: -10.51% median: -11.70% win: 25% σ: 10.46% n: 4 2022-04-12 → 2026-05-29 | ADPT Apr avg: -13.68% median: -18.38% win: 20% σ: 13.84% n: 5 2022-04-12 → 2026-05-29 | ADPT May avg: 12.15% median: 7.45% win: 60% σ: 17.44% n: 5 2022-04-12 → 2026-05-29 | ADPT Jun avg: 6.79% median: 4.19% win: 75% σ: 11.03% n: 4 2022-04-12 → 2026-05-29 (current) | ADPT Jul avg: 13.15% median: 19.46% win: 75% σ: 17.84% n: 4 2022-04-12 → 2026-05-29 | ADPT Aug avg: 2.40% median: 0.34% win: 50% σ: 20.09% n: 4 2022-04-12 → 2026-05-29 | ADPT Sep avg: -4.31% median: -5.28% win: 50% σ: 18.03% n: 4 2022-04-12 → 2026-05-29 | ADPT Oct avg: 0.33% median: 1.90% win: 50% σ: 15.45% n: 4 2022-04-12 → 2026-05-29 | ADPT Nov avg: 11.87% median: 13.05% win: 75% σ: 9.93% n: 4 2022-04-12 → 2026-05-29 | ADPT Dec avg: -4.40% median: -6.03% win: 50% σ: 13.36% n: 4 2022-04-12 → 2026-05-29 |